These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 29428109)

  • 21. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer.
    Asaoka T; Miyamoto A; Maeda S; Tsujie M; Hama N; Yamamoto K; Miyake M; Haraguchi N; Nishikawa K; Hirao M; Ikeda M; Sekimoto M; Nakamori S
    Pancreatology; 2016; 16(3):434-40. PubMed ID: 26852169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
    Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T
    Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients' survival.
    Yu XZ; Guo ZY; Di Y; Yang F; Ouyang Q; Fu DL; Jin C
    Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):104-109. PubMed ID: 28119265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX.
    Tanaka M; Heckler M; Mihaljevic AL; Sun H; Klaiber U; Heger U; Büchler MW; Hackert T
    Eur J Surg Oncol; 2019 Aug; 45(8):1453-1459. PubMed ID: 30981446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pattern of lymph node metastasis spread in pancreatic cancer.
    Kanda M; Fujii T; Nagai S; Kodera Y; Kanzaki A; Sahin TT; Hayashi M; Yamada S; Sugimoto H; Nomoto S; Takeda S; Morita S; Nakao A
    Pancreas; 2011 Aug; 40(6):951-5. PubMed ID: 21441841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined preoperative platelet-to-lymphocyte ratio and serum carbohydrate antigen 19-9 level as a prognostic factor in patients with resected pancreatic cancer.
    Sakamoto T; Saito H; Amisaki M; Tokuyasu N; Honjo S; Fujiwara Y
    Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):278-284. PubMed ID: 30987900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma.
    Kondo N; Murakami Y; Uemura K; Nakagawa N; Takahashi S; Ohge H; Sueda T
    Pancreatology; 2017; 17(1):95-102. PubMed ID: 27746094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.
    Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T
    Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive Factors for Elevated Postoperative Carbohydrate Antigen 19-9 Levels in Patients With Resected Pancreatic Cancer.
    Takagi C; Kikuchi Y; Shirakawa H; Hoshimoto S; Tomikawa M; Ozawa I; Hishinuma S; Ogata Y
    Anticancer Res; 2019 Jun; 39(6):3177-3183. PubMed ID: 31177164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9.
    Li D; Peng Q; Wang L; Cai W; Liang M; Liu S; Ma X; Zhao X
    Eur Radiol; 2024 Jan; 34(1):509-524. PubMed ID: 37507611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unexpected Para-aortic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: a Contraindication to Resection?
    Kim JS; Hwang HK; Lee WJ; Kang CM
    J Gastrointest Surg; 2020 Dec; 24(12):2789-2799. PubMed ID: 31792906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Impact of Para-Aortic Lymph Node Micrometastasis in Pancreatic Ductal Adenocarcinoma.
    Komo T; Murakami Y; Kondo N; Uemura K; Hashimoto Y; Nakagawa N; Urabe K; Takahashi S; Sueda T
    Ann Surg Oncol; 2016 Jun; 23(6):2019-27. PubMed ID: 26856722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CA19-9 as a predictor of resectability in patients with borderline resectable pancreatic cancer.
    He Z; Lu H; Du X; Hu W; Zhaoda BT
    Hepatogastroenterology; 2013 Jun; 60(124):900-3. PubMed ID: 23321027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer.
    Doi R; Kami K; Ito D; Fujimoto K; Kawaguchi Y; Wada M; Kogire M; Hosotani R; Imamura M; Uemoto S
    World J Surg; 2007 Jan; 31(1):147-54. PubMed ID: 17171496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Factors influencing survival of patients with cancer of the pancreatic head after resection].
    Gao CT; Li HK; Li Q
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):554-7. PubMed ID: 19950708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of lymph node micrometastasis in pancreatic cancer patients.
    Kaťuchová J; Bober J; Kaťuch V; Radoňak J
    Eur Surg Res; 2012; 48(1):10-5. PubMed ID: 22398863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2014 May; 34(5):2389-94. PubMed ID: 24778048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.
    Xu HX; Liu L; Xiang JF; Wang WQ; Qi ZH; Wu CT; Liu C; Long J; Xu J; Ni QX; Yu XJ
    Surgery; 2017 Feb; 161(2):373-384. PubMed ID: 27838102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.